MOLECULAR PARTNERS N/ CH0256379097 /
| 2024-04-19 5:30:11 PM | Chg. +0.0200 | Volume | Bid5:40:00 PM | Ask5:40:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 3.3700CHF | +0.60% | 24,802 Turnover: 82,200.5750 |
3.2750Bid Size: 53 | 3.5000Ask Size: 3,000 | 122.51 mill.CHF | - | - |
Assets
| 2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 2.4000 | 1.9000 | 1.5000 | 4.2000 | 9.4000 | ||||||
| Intangible Assets | 0.0000 | 0.0000 | .4000 | .8000 | .3000 | ||||||
| Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Fixed Assets | 2.5000 | 1.9000 | 1.8000 | 5 | 9.7000 | ||||||
| Inventories | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Accounts Receivable | .8000 | 1.1000 | 51.6000 | 2.3000 | 2.8000 | ||||||
| Cash and Cash Equivalents | 149.7000 | 131.3000 | 99 | 75.7000 | 133.7000 | ||||||
| Current Assets | 181.6000 | 142.5000 | 153.3000 | 99.9000 | 177.8000 | ||||||
| Total Assets | 184.1000 | 144.4000 | 155.2000 | 104.9000 | 187.5000 | ||||||
Liabilities
| 2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1.4000 | 1.3000 | 2.6000 | 2.4000 | 5.8000 | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Provisions | 4 | 4 | 6.4000 | 6.6000 | 7.7000 | ||||||
| Liabilities | 42.7000 | 27.7000 | 63.5000 | 50.8000 | 80.3000 | ||||||
| Share Capital | 2.1000 | 2.1000 | 2.1000 | 2.1600 | 2.9150 | ||||||
| Total Equity | 141.4000 | 116.7000 | 91.7000 | 54.1000 | 107.2000 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 184.1000 | 144.4000 | 155.2000 | 104.9000 | 187.5000 | ||||||
Income Statement
| 2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 23 | 20 | 10.4000 | 20.4000 | 9.3000 | ||||||
| Depreciation (total) | 1.1000 | 1.1000 | .9000 | - | - | ||||||
| Operating Result | -19.5000 | -25.8000 | -37.4000 | -36.7000 | -58.3000 | ||||||
| Interest Income | - | - | - | - | - | ||||||
| Income Before Taxes | -18.6000 | -25.4000 | -37 | -36.3000 | -62.8000 | ||||||
| Income Taxes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -18.6000 | -25.4000 | -37 | -36.3000 | -62.8000 | ||||||
Per Share
Cash Flow
| 2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -35.4000 | -40 | -42.5000 | -1.2000 | -29 | ||||||
| Cash Flow from Investing Activities | -11.3000 | -20.9000 | 9.6000 | -19.8000 | -21.7000 | ||||||
| Cash Flow from Financing | .4000 | .8000 | .4000 | -.2000 | 113.2000 | ||||||
| Decrease / Increase in Cash | -45.6000 | -18.4000 | -32.4000 | -23.2000 | 58 | ||||||
| Employees | 103 | 108 | 118 | 145 | 157 | ||||||
